(NKE) Nike - Ratings and Ratios
Footwear, Apparel, Accessories, Equipment, Digital
Dividends
| Dividend Yield | 2.44% |
| Yield on Cost 5y | 1.25% |
| Yield CAGR 5y | 10.58% |
| Payout Consistency | 86.5% |
| Payout Ratio | 82.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.9% |
| Value at Risk 5%th | 44.4% |
| Relative Tail Risk | -15.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -29.76 |
| CAGR/Max DD | -0.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.493 |
| Beta | 1.031 |
| Beta Downside | 0.905 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.40% |
| Mean DD | 28.52% |
| Median DD | 28.60% |
Description: NKE Nike December 02, 2025
Nike Inc. (NYSE:NKE) designs, develops, markets and sells athletic footwear, apparel, equipment and related services worldwide under brands such as Nike, Jordan, Converse and others. Its distribution network spans owned retail stores, e-commerce platforms, wholesale partners and licensed outlets, serving men, women and children across North America, Europe, Greater China, the Asia-Pacific and emerging markets.
Key recent metrics: FY 2023 revenue reached $51.2 billion, with digital sales growing 15% YoY and now representing roughly 30% of total revenue; direct-to-consumer (DTC) sales accounted for 38% of the mix, driving higher gross margins (≈ 45%). The company’s performance is sensitive to discretionary consumer spending, global footwear demand trends and supply-chain constraints, while a strong brand pipeline and continued expansion of its Nike App and membership ecosystem act as tailwinds.
For a deeper quantitative view of Nike’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.90b TTM) > 0 and > 6% of Revenue (6% = 2.79b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -10.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 27.97% (prev 28.82%; Δ -0.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 3.53b > Net Income 2.90b (YES >=105%, WARN >=100%) |
| Net Debt (4.04b) to EBITDA (4.29b) ratio: 0.94 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.48b) change vs 12m ago -1.53% (target <= -2.0% for YES) |
| Gross Margin 41.94% (prev 44.84%; Δ -2.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 123.5% (prev 132.1%; Δ -8.56pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 12.56 (EBITDA TTM 4.29b / Interest Expense TTM 277.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.80
| (A) 0.35 = (Total Current Assets 23.90b - Total Current Liabilities 10.91b) / Total Assets 37.33b |
| (B) -0.02 = Retained Earnings (Balance) -700.0m / Total Assets 37.33b |
| (C) 0.09 = EBIT TTM 3.48b / Avg Total Assets 37.60b |
| (D) -0.04 = Book Value of Equity -1.00b / Total Liabilities 23.87b |
| Total Rating: 2.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.91
| 1. Piotroski 5.50pt |
| 2. FCF Yield 3.07% |
| 3. FCF Margin 6.48% |
| 4. Debt/Equity 0.82 |
| 5. Debt/Ebitda 0.94 |
| 6. ROIC - WACC (= 3.53)% |
| 7. RoE 21.16% |
| 8. Rev. Trend -14.46% |
| 9. EPS Trend -57.30% |
What is the price of NKE shares?
Over the past week, the price has changed by +2.55%, over one month by +6.71%, over three months by -10.32% and over the past year by -14.20%.
Is NKE a buy, sell or hold?
- Strong Buy: 13
- Buy: 6
- Hold: 20
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the NKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 83.3 | 26.5% |
| Analysts Target Price | 83.3 | 26.5% |
| ValueRay Target Price | 60.5 | -8.2% |
NKE Fundamental Data Overview November 29, 2025
P/E Trailing = 33.1436
P/E Forward = 39.6825
P/S = 2.0572
P/B = 7.0606
P/EG = 2.6473
Beta = 1.293
Revenue TTM = 46.44b USD
EBIT TTM = 3.48b USD
EBITDA TTM = 4.29b USD
Long Term Debt = 8.00b USD (from longTermDebt, last quarter)
Short Term Debt = 510.0m USD (from shortTermDebt, last quarter)
Debt = 11.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.04b USD (from netDebt column, last quarter)
Enterprise Value = 98.02b USD (95.54b + Debt 11.06b - CCE 8.57b)
Interest Coverage Ratio = 12.56 (Ebit TTM 3.48b / Interest Expense TTM 277.0m)
FCF Yield = 3.07% (FCF TTM 3.01b / Enterprise Value 98.02b)
FCF Margin = 6.48% (FCF TTM 3.01b / Revenue TTM 46.44b)
Net Margin = 6.23% (Net Income TTM 2.90b / Revenue TTM 46.44b)
Gross Margin = 41.94% ((Revenue TTM 46.44b - Cost of Revenue TTM 26.96b) / Revenue TTM)
Gross Margin QoQ = 42.18% (prev 40.27%)
Tobins Q-Ratio = 2.63 (Enterprise Value 98.02b / Total Assets 37.33b)
Interest Expense / Debt = 0.57% (Interest Expense 63.0m / Debt 11.06b)
Taxrate = 21.15% (195.0m / 922.0m)
NOPAT = 2.74b (EBIT 3.48b * (1 - 21.15%))
Current Ratio = 2.19 (Total Current Assets 23.90b / Total Current Liabilities 10.91b)
Debt / Equity = 0.82 (Debt 11.06b / totalStockholderEquity, last quarter 13.47b)
Debt / EBITDA = 0.94 (Net Debt 4.04b / EBITDA 4.29b)
Debt / FCF = 1.34 (Net Debt 4.04b / FCF TTM 3.01b)
Total Stockholder Equity = 13.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 2.90b / Total Assets 37.33b)
RoE = 21.16% (Net Income TTM 2.90b / Total Stockholder Equity 13.68b)
RoCE = 16.04% (EBIT 3.48b / Capital Employed (Equity 13.68b + L.T.Debt 8.00b))
RoIC = 12.37% (NOPAT 2.74b / Invested Capital 22.17b)
WACC = 8.84% (E(95.54b)/V(106.60b) * Re(9.81%) + D(11.06b)/V(106.60b) * Rd(0.57%) * (1-Tc(0.21)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.75%
[DCF Debug] Terminal Value 71.99% ; FCFE base≈4.69b ; Y1≈4.66b ; Y5≈4.89b
Fair Price DCF = 54.11 (DCF Value 64.36b / Shares Outstanding 1.19b; 5y FCF grow -1.27% → 3.0% )
EPS Correlation: -57.30 | EPS CAGR: -13.11% | SUE: 2.92 | # QB: 1
Revenue Correlation: -14.46 | Revenue CAGR: 0.84% | SUE: 1.69 | # QB: 2
EPS next Quarter (2026-02-28): EPS=0.48 | Chg30d=+0.001 | Revisions Net=-1 | Analysts=21
EPS current Year (2026-05-31): EPS=1.69 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=-22.0% | Growth Revenue=+1.0%
EPS next Year (2027-05-31): EPS=2.53 | Chg30d=+0.001 | Revisions Net=+0 | Growth EPS=+50.0% | Growth Revenue=+5.2%
Additional Sources for NKE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle